Exela Pharm Sci Private Limited

Exela Pharm Sci Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
CIN U24231TG2004PTC125972 Incorporated 26 May 2004 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Private Limited Company pharma
Revenue · FY 2025
₹2.34 Cr
▲ 1046% YoY
Net profit · FY 2025
₹19.4 Lakh
Net margin 8.3%
EBITDA · FY 2025
₹21.35 Lakh
EBITDA margin 9.1%
Authorised capital
₹3 Cr
Registered with MCA
Paid-up capital
₹1.93 Cr
Issued & subscribed
Company age
22 yrs
Est. 2004
Employees · EPFO
22
Provident fund records
Directors on board
3
As per MCA filings

About Exela Pharm Sci Private Limited

Data last updated:

Exela Pharm Sci Private Limited is a private limited company based in Hyderabad, Telangana, India, a subsidiary of Exela Holding Llc. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 26 May 2004 and has been in existence for over 22 years.

The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24231TG2004PTC125972. Its GSTIN is 36AABCE3320K2ZV (Telangana). The company holds 3 GST registrations, of which 1 is active.

The company has an authorised share capital of ₹3 Cr and a paid-up capital of ₹1.93 Cr. It is led by directors including Murali Krishna Reddy Adala and Saba Nayagam Ganapathi.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 4th Floor Park Citi Plaza Road No.1 Banjara Hills, Hyderabad, Telangana, India – 500082.

As per the financials filed for FY 2025, the company reported a revenue of ₹2.34 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹19.4 Lakh (net margin 8.3%) and EBITDA of ₹21.35 Lakh (EBITDA margin 9.1%). Revenue has grown at a compounded annual rate (CAGR) of 16% over three years and 49% over five years.

The company has about 22 employees on its provident fund (EPFO) records.

Court records list 2 cases involving the company, including 2 filed by the company.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U24231TG2004PTC125972
Registration Number 125972
Incorporation Date 26 May 2004
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Parent Company Exela Holding Llc
Compliance Status Active Compliant

CIN history

Exela Pharm Sci has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U24231TG2004PTC125972, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24231TG2004PTC125972Current
U24231KA2004ULT034012Previous
U24231KA2004PTC034012Previous

Contact details

Exela Pharm Sci Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    4th Floor Park Citi Plaza Road No.1 Banjara Hills, Hyderabad, Telangana, India – 500082
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Exela Pharm Sci Private Limited, buy the company report.

Comprehensive company report
Exela Pharm Sci Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Exela Pharm Sci is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Exela Pharm Sci Private Limited, buy the company report.

Financials of Exela Pharm Sci Private Limited

FY 2025 filings available

Exela Pharm Sci Private Limited reported revenue of ₹2.34 Cr (up 1046% YoY) for FY 2025.

Revenue · FY 2025
₹2.34 Cr ▲ 1046%
Net profit · FY 2025
₹19.4 Lakh margin 8.3%
EBITDA · FY 2025
₹21.35 Lakh margin 9.1%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
3 years · compounded
▲ 16%
5 years · compounded
▲ 49%
EBITDA CAGR growth
1 year
▲ 114%
3 years · compounded
▲ 12%

Revenue has grown at a compounded annual rate (CAGR) of 49% over five years. EBITDA rose 114% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹21.35 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹19.4 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin9.1%
Net Profit Margin8.3%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Exela Pharm Sci Private Limited, buy the company report.

Board of directors of Exela Pharm Sci Private Limited

Exela Pharm Sci has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Murali Krishna Reddy AdalaDirector26 May 200422 Years 5 MonthsCurrent
Saba Nayagam GanapathiDirector11 Jul 201610 Years 4 MonthsCurrent
Phanesh Babu KoneruDirector29 Sep 200521 Years 1 MonthsCurrent

Auditor

Exela Pharm Sci Private Limited is audited by REDDY A V & CO for the financial year 2021.

Auditor firmFinancial yearFirm registration number
REDDY A V & COFY 2021003256S

Shareholding

The shareholding of Exela Pharm Sci Private Limited is on record for 5 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2021FY 2020FY 2019FY 2017FY 2016
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Exela Pharm Sci Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Exela Pharm Sci Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Exela Pharm Sci Private Limited has a workforce of 22 employees on its EPFO records as of Apr 2026, across 1 active EPFO establishment.

Employee count
22
Active EPFO establishments
1
Employee growth
4.8%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-2722
FY 2025-26
FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21
FY 2019-20

To see the full employee and EPFO history of Exela Pharm Sci Private Limited, buy the company report.

GST

Exela Pharm Sci has 3 GST registrations: 1 active and 2 cancelled or inactive.

Total GSTINs
3
Active
1
Cancelled / inactive
2
GSTINStateStatusRegistered on
36AABCE3320K2ZVTelanganaActive27 Sep 2017

To see the full GST registrations and return filing status of Exela Pharm Sci Private Limited, buy the company report.

Recent activity

Exela Pharm Sci Private Limited has 4 board changes on record since 2004: 3 appointments and 1 cessation. The latest: Saba Nayagam Ganapathi was appointed as Director on 11 Jul 2016.

AGM
Exela Pharm Sci Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Exela Pharm Sci Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Appointed
Saba Nayagam Ganapathi was appointed as Director.
Ceased
Sree Rama Murthy Mallipeddi ceased to be Director.
Appointed
Phanesh Babu Koneru was appointed as Director.
Appointed
Murali Krishna Reddy Adala was appointed as Director.
Incorporation
26 May 2004
Exela Pharm Sci Private Limited was registered on 26 May 2004 with Roc Hyderabad & aged 22 years 5 months as per MCA records.

Frequently asked questions

Exela Pharm Sci is an active private limited company based in Hyderabad, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 26 May 2004 (22+ years old) and is registered under CIN U24231TG2004PTC125972.

Exela Pharm Sci has 3 current directors:

The latest financial statements of Exela Pharm Sci on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Exela Pharm Sci is 36AABCE3320K2ZV, registered in Telangana. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.

The CIN (Corporate Identification Number) of Exela Pharm Sci is U24231TG2004PTC125972. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Exela Pharm Sci has 2 court cases on record: 2 filed by the company.

Exela Pharm Sci was incorporated on 26 May 2004, making it 22+ years old. It is registered with the Registrar of Companies, Hyderabad.

Saba Nayagam Ganapathi was appointed as Director on 11 Jul 2016. Sree Rama Murthy Mallipeddi ceased to be Director on 03 Sep 2007. Phanesh Babu Koneru was appointed as Director on 29 Sep 2005. Exela Pharm Sci has 4 board changes on record in total.

The registered office of Exela Pharm Sci is at 4th Floor Park Citi Plaza Road No.1 Banjara Hills, Hyderabad, Telangana, India – 500082.

Exela Pharm Sci operates in the pharma industry, in the pharmaceutical retailers and distributors segment.